Deutsche Bank initiates coverage on Acorda Therapeutics (Nasdaq: ACOR) with a Buy.

Deutsche analyst says, "Given 2 successful Ph3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE